A detailed history of Post Resch Tallon Group Inc. transactions in Codexis, Inc. stock. As of the latest transaction made, Post Resch Tallon Group Inc. holds 559,935 shares of CDXS stock, worth $923,892. This represents 1.21% of its overall portfolio holdings.

Number of Shares
559,935
Previous 467,301 19.82%
Holding current value
$923,892
Previous $1.14 Billion 19.82%
% of portfolio
1.21%
Previous 1.1%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 04, 2025

BUY
$2.35 - $3.33 $217,689 - $308,471
92,634 Added 19.82%
559,935 $1.37 Billion
Q2 2025

Jul 09, 2025

SELL
$1.97 - $2.64 $2,533 - $3,395
-1,286 Reduced 0.27%
467,301 $1.14 Billion
Q1 2025

Apr 22, 2025

BUY
$2.53 - $5.43 $164,247 - $352,515
64,920 Added 16.08%
468,587 $1.16 Billion
Q4 2024

Feb 03, 2025

BUY
$2.91 - $5.81 $1.17 Million - $2.35 Million
403,667 New
403,667 $2.02 Billion

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $108M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Post Resch Tallon Group Inc. Portfolio

Follow Post Resch Tallon Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Post Resch Tallon Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Post Resch Tallon Group Inc. with notifications on news.